Simultaneous medullary and papillary thyroid cancer: A novel entity?

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 37-44

  MacHens, Andreas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MUTATION; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 84856678368     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1795-z     Document Type: Article

References (30)

1. RP Biscolla C Ugolini M Sculli V Bottici MG Castagna C Romei, et al. 2004 Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior Thyroid. 14 946 952 15671773 10.1089/thy.2004.14.946
2. WG Kim G Gong EY Kim TY Kim SJ Hong W Bae Kim, et al. 2010 Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental Clin Endocrinol 72 256 263 10.1111/j.1365-2265.2009.03622.x
3. L Davies HG Welch 2002 Increasing incidence of thyroid cancer in the United States, 1973-2002 J Am Med Assoc 295 2164 2167 10.1001/jama.295.18.2164
4. P Trimboli S Ulisse FM Graziano A Marzullo M Ruggieri A Calvanese, et al. 2006 Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years Thyroid. 16 1151 1155 17123342 10.1089/thy.2006.16.1151 1:STN:280:DC%2BD28nos1egtQ%3D%3D
5. M Colonna AV Guizard C Schvartz M Velten N Raverdy F Molinie, et al. 2007 A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000) Eur J Cancer 43 891 900 17289376 10.1016/j.ejca.2006.11.024 1:STN:280: DC%2BD2s7kvVGruw%3D%3D
6. RT Netea-Maier KKH Aben MK Casparie M den Heijer JMM Grefte P Slootweg, et al. 2008 Trends in incidence and mortality of thyroid carcinoma in the Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery Int J Cancer 123 1681 1684 18623130 10.1002/ijc.23678 1:CAS:528:DC%2BD1cXhtV2ru7zL
7. AY Chen A Jemal EM Ward 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005 Cancer. 115 3801 3807 19598221 10.1002/cncr.24416
8. L Enewold K Zhu E Ron AJ Marrogi A Stojadinovic GE Peoples, et al. 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 Cancer Epidemiol Biomarkers Prev 18 784 791 19240234 10.1158/1055-9965.EPI-08-0960
9. SF Hall H Walker R Siemens A Schneeberg 2009 Increasing detection and increasing incidence in thyroid cancer World J Surg 33 2567 2571 19789911 10.1007/s00268-009-0226-9
10. A Rego-Iraeta LF Pérez-Méndez B Mantinan RV Garcia-Mayor 2009 Time trends for thyroid cancer in Northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma Thyroid. 19 333 340 19355823 10.1089/thy.2008.0210
11. A Machens H Dralle 2010 Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995-2009 Eur J Endocrinol 163 111 119 20447999 10.1530/EJE-10-0203 1:CAS:528:DC%2BC3cXpsFeisr0%3D
12. H Völzke J Lüdemann DM Robinson KW Spieker C Schwahn A Kramer, et al. 2003 The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area Thyroid. 13 803 810 14558922 10.1089/105072503768499680
13. H Dralle 2002 Lymph node dissection and medullary thyroid carcinoma Br J Surg 89 1073 1075 12190669 10.1046/j.1365-2168.2002.02160.x 1:STN:280: DC%2BD38vjsVWjtw%3D%3D
14. Dralle H. [Malignant thyroid tumors]. In: Garbe C, Albers P, Beckmann MW, Bokemeyer C, Bootz F, Creutzig U, et al, editors. Kurzgefate interdisziplinäre Leitlinien [Abbreviated interdisciplinary guidelines 2006]. Munich: Zuckschwerdt Verlag; 2006 (in German).
15. World Health Organisation International Histological Classification of Tumours. 2nd ed. Berlin: Springer; 1988.
16. DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press; 2004.
17. A Machens K Lorenz H Dralle 2009 Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels Ann Surg 250 305 310 19638924 10.1097/SLA.0b013e3181ae333f
18. P Niccoli N Wion-Barbot P Caron JF Henry C de Micco JP Saint Andre, et al. 1997 The French Medullary Study Group Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients J Clin Endocrinol Metab 82 338 341 9024213 10.1210/jc.82.2.338 1:CAS:528: DyaK2sXhtVWqtL8%3D
19. R Elisei V Bottici F Luchetti G Di Coscio C Romei L Grasso, et al. 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10, 864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 163 168 14715844 10.1210/jc.2003-030550 1:CAS:528:DC%2BD2cXmvFeqsA%3D%3D
20. G Costante D Meringolo C Durante D Bianchi M Nocera S Tumino, et al. 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules J Clin Endocrinol Metab 92 450 455 17119000 10.1210/jc.2006-1590 1:CAS:528:DC%2BD2sXitVaks7k%3D
21. C Scheuba K Kaserer A Moritz R Drosten H Vierhapper C Bieglmayer, et al. 2009 Sporadic hypercalcitoninemia. Clinical and therapeutic consequences Endocr Relat Cancer 16 243 253 18987170 10.1677/ERC-08-0059 1:STN:280: DC%2BD1M3jvVWjsQ%3D%3D
22. T Rink PN Truong HJ Schroth J Diener M Zimny F Grünwald 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease Thyroid. 19 327 332 19355822 10.1089/thy.2008.0102 1:CAS:528:DC%2BD1MXkt1Cgsbs%3D
23. A Machens F Hoffmann C Sekulla H Dralle 2009 Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer Endocr Relat Cancer 16 1291 1298 19726541 10.1677/ERC-09-0136 1:CAS:528:DC%2BC3cXhtFOnsro%3D
24. W Karges H Dralle F Raue K Mann C Reiners M Grussendorf, et al. 2004 Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendations Exp Clin Endocrinol Diabetes 112 52 58 14758572 10.1055/s-2004-815727 1:CAS:528:DC%2BD2cXhslOgs70%3D
25. F Pacini M Schlumberger H Dralle R Elisei JWA Smit W Wiersinga, et al. 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 787 803 16728537 10.1530/eje.1.02158 1:CAS:528:DC%2BD28XmsVKrurY%3D
26. Thamm M, Ellert U, Thierfelder W, Liesenkötter KP, Völzke H. [Iodine intake in Germany. Results of iodine monitoring in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2007;50:744-9 (in German).
27. S Hölzer C Reiners K Mann M Bamberg M Rothmund J Dudeck, et al. 2000 Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996 Cancer. 89 192 201 10897018 10.1002/1097-0142(20000701)89:1<192::AID-CNCR26>3.0.CO;2-7
28. AL Shifrin C Xenachis A Fay TJ Matulewicz YH Kuo JJ Vernick 2009 One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome-MEN 2C? Surgery. 146 998 1005 19958926 10.1016/j.surg.2009.09.021
29. A Machens H Dralle 2008 Familial prevalence and age of RET germline mutations: implications for screening Clin Endocrinol 69 81 87 10.1111/j.1365-2265.2007.03153.x 1:CAS:528:DC%2BD1cXptFykurc%3D
30. C Romei S Mariotti L Fugazzola A Taccaliti F Pacini G Opocher, et al. 2010 Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes Eur J Endocrinol 163 301 308 20516206 10.1530/EJE-10-0333 1:CAS:528: DC%2BC3cXhtFSksrjL